Why Dicerna Pharmaceuticals Stock Is Rocketing Higher Today
Shares of Dicerna Pharmaceuticals (NASDAQ: DRNA), a clinical-stage biopharmaceutical company, are exploding higher today in response to a buyout offer from Novo Nordisk (NYSE: NVO). Dicerna stock was up 78.6% as of 11 a.m. ET on Thursday.
Today, Novo Nordisk agreed to acquire all of Dicerna's outstanding shares for $38.25 each. That's a premium of 80% above the stock's price after the market closed yesterday.
Image source: Getty Images.
Source Fool.com